Join APA's policy staff to hear an overview of the DEA's proposed rule on Special Registration for Telemedicine and Limited State Telemedicine Registration and provide feedback to provisions of the proposed rule on how it may impact your practice. The proposed rule applies where the prescribing practitioner wishes to prescribe controlled substances and has never conducted an in-person medical evaluation of the patient prior to the issuance of the prescription. APA will use information shared during the listening session to formulate a response to the DEA.
This search input has a predictive search function. When 3 letters or more are entered, a number of predictive results appear in a dropdown. Use arrow keys to navigate and use the enter key to go to the page highlighted.